|
Resolution: standard / high Figure 2.
Adalimumab plus methotrexate in active rheumatoid arthritis: mean change from baseline in total Sharp score. *P < 0.01, †P ≤ 0.001, versus placebo. MTX, methotrexate. Reproduced with permission [18]. Copyright © 2004 by John Wiley & Sons, Inc.
Moreland Arthritis Research & Therapy 2005 7(Suppl 3):S2 doi:10.1186/ar1736 |